---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-083973"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2024-07-30T23:59:59+00:00"
generated_at: "2026-05-31T15:23:27.541709+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed appoints John Mack to board; former Medtronic Cardiac Surgery President

## Summary
- John Mack appointed as Class I director effective July 29, 2024; term expires at 2027 annual meeting.
- Mack previously served as Medtronic's President of Cardiac Surgery and led business development for its $3.2B coronary/structural heart business.
- Appointed to Audit Committee; Board size increased from 7 to 8 directors.
- No family relationships or transactions requiring disclosure under Item 404(a).
- Mack will receive standard non-employee director compensation per existing policy.

## SEC filing metadata
- accession: 0001104659-24-083973
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2024-07-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465924083973/0001104659-24-083973-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465924083973/tm2420397d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-083973
- JSON: https://secwatch.observer/filing/0001104659-24-083973.json
- Plain text: https://secwatch.observer/filing/0001104659-24-083973.txt

## Key facts
- Executive change
  John Mack was appointed as Director at Orchestra BioMed Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 29, 2024, the Board of Directors (the “ Board ”) of Orchestra BioMed Holdings, Inc. (the “ Company ”) appointed John Mack to serve as a Class I director, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1814114/000110465924083973/0001104659-24-083973-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.